ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-110056,MAPK3 (ERK1) activation,1/8,10/10899,0.007318937898849631,0.08668755509705489,0.05873566951524591,IL6ST,1
R-HSA-1059683,Interleukin-6 signaling,1/8,11/10899,0.008048247155605037,0.08668755509705489,0.05873566951524591,IL6ST,1
R-HSA-9020956,Interleukin-27 signaling,1/8,11/10899,0.008048247155605037,0.08668755509705489,0.05873566951524591,IL6ST,1
R-HSA-8984722,Interleukin-35 Signalling,1/8,12/10899,0.008777087532419459,0.08668755509705489,0.05873566951524591,IL6ST,1
R-HSA-879415,Advanced glycosylation endproduct receptor signaling,1/8,13/10899,0.009505459287699858,0.08668755509705489,0.05873566951524591,APP,1
R-HSA-975577,N-Glycan antennae elongation,1/8,15/10899,0.01096079796669569,0.08668755509705489,0.05873566951524591,B4GALT5,1
R-HSA-844456,The NLRP3 inflammasome,1/8,16/10899,0.011687765406632078,0.08668755509705489,0.05873566951524591,APP,1
R-HSA-6788467,IL-6-type cytokine receptor ligand interactions,1/8,17/10899,0.012414265257477242,0.08668755509705489,0.05873566951524591,IL6ST,1
R-HSA-622312,Inflammasomes,1/8,21/10899,0.015315593924453363,0.08668755509705489,0.05873566951524591,APP,1
R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,1/8,22/10899,0.016039759694687405,0.08668755509705489,0.05873566951524591,APP,1
R-HSA-8863678,Neurodegenerative Diseases,1/8,22/10899,0.016039759694687405,0.08668755509705489,0.05873566951524591,APP,1
R-HSA-9609523,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,1/8,22/10899,0.016039759694687405,0.08668755509705489,0.05873566951524591,APP,1
R-HSA-112409,RAF-independent MAPK1/3 activation,1/8,23/10899,0.016763459420939153,0.08668755509705489,0.05873566951524591,IL6ST,1
R-HSA-6783589,Interleukin-6 family signaling,1/8,24/10899,0.017486693360313388,0.08668755509705489,0.05873566951524591,IL6ST,1
R-HSA-933542,TRAF6 mediated NF-kB activation,1/8,25/10899,0.018209461769795543,0.08668755509705489,0.05873566951524591,APP,1
R-HSA-9734009,Defective Intrinsic Pathway for Apoptosis,1/8,25/10899,0.018209461769795543,0.08668755509705489,0.05873566951524591,APP,1
R-HSA-9660826,Purinergic signaling in leishmaniasis infection,1/8,26/10899,0.018931764906253368,0.08668755509705489,0.05873566951524591,APP,1
R-HSA-9664424,Cell recruitment (pro-inflammatory response),1/8,26/10899,0.018931764906253368,0.08668755509705489,0.05873566951524591,APP,1
R-HSA-975576,N-glycan antennae elongation in the medial/trans-Golgi,1/8,26/10899,0.018931764906253368,0.08668755509705489,0.05873566951524591,B4GALT5,1
R-HSA-2022854,Keratan sulfate biosynthesis,1/8,28/10899,0.02037497638697605,0.08863114728334581,0.06005256198266626,B4GALT5,1
R-HSA-8866652,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,1/8,30/10899,0.021816329855061545,0.09038193797096926,0.0612388206457868,UBE2H,1
R-HSA-1638074,Keratan sulfate/keratin metabolism,1/8,34/10899,0.024693470954203933,0.09612213221965903,0.0651281234640158,B4GALT5,1
R-HSA-432720,Lysosome Vesicle Biogenesis,1/8,35/10899,0.025411598173013306,0.09612213221965903,0.0651281234640158,APP,1
R-HSA-445989,TAK1-dependent IKK and NF-kappa-B activation  ,1/8,45/10899,0.032567463395452356,0.11581619161553659,0.07847195076188808,APP,1
R-HSA-1660662,Glycosphingolipid metabolism,1/8,46/10899,0.033280514832050745,0.11581619161553659,0.07847195076188808,UGCG,1
R-HSA-3214842,HDMs demethylate histones,1/8,50/10899,0.036128124060428424,0.12089026127912589,0.08190991689813733,ARID5B,1
R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",1/8,57/10899,0.04109378272060593,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-447115,Interleukin-12 family signaling,1/8,57/10899,0.04109378272060593,0.1252581263128015,0.08486938987921215,IL6ST,1
R-HSA-9013406,RHOQ GTPase cycle,1/8,59/10899,0.04250842450020054,0.1252581263128015,0.08486938987921215,DLC1,1
R-HSA-449147,Signaling by Interleukins,2/8,473/10899,0.0442331748310325,0.1252581263128015,0.08486938987921215,IL6ST/APP,2
R-HSA-913709,O-linked glycosylation of mucins,1/8,63/10899,0.0453322307663917,0.1252581263128015,0.08486938987921215,B4GALT5,1
R-HSA-9013026,RHOB GTPase cycle,1/8,70/10899,0.050256360865723604,0.1252581263128015,0.08486938987921215,DLC1,1
R-HSA-199992,trans-Golgi Network Vesicle Budding,1/8,72/10899,0.05165916688326555,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-9013106,RHOC GTPase cycle,1/8,74/10899,0.05306015956975263,0.1252581263128015,0.08486938987921215,DLC1,1
R-HSA-3000178,ECM proteoglycans,1/8,76/10899,0.054459340934695066,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-8852135,Protein ubiquitination,1/8,79/10899,0.05655472114544524,0.1252581263128015,0.08486938987921215,UBE2H,1
R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,1/8,82/10899,0.058646037167509824,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-428157,Sphingolipid metabolism,1/8,90/10899,0.06420306189536595,0.1252581263128015,0.08486938987921215,UGCG,1
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,1/8,97/10899,0.069041890671802,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,1/8,97/10899,0.069041890671802,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-975871,MyD88 cascade initiated on plasma membrane,1/8,97/10899,0.069041890671802,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,1/8,103/10899,0.0731720185842697,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-975155,MyD88 dependent cascade initiated on endosome,1/8,104/10899,0.0738588121977678,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,1/8,105/10899,0.07454516046107662,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,1/8,105/10899,0.07454516046107662,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-9645723,Diseases of programmed cell death,1/8,105/10899,0.07454516046107662,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,1/8,108/10899,0.07660153562483618,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-8957275,Post-translational protein phosphorylation,1/8,108/10899,0.07660153562483618,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-166166,MyD88-independent TLR4 cascade ,1/8,110/10899,0.07797023018516691,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,1/8,110/10899,0.07797023018516691,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-5173105,O-linked glycosylation,1/8,111/10899,0.07865391154196744,0.1252581263128015,0.08486938987921215,B4GALT5,1
R-HSA-977225,Amyloid fiber formation,1/8,111/10899,0.07865391154196744,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,1/8,113/10899,0.080019943643172,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,1/8,113/10899,0.080019943643172,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-9020702,Interleukin-1 signaling,1/8,115/10899,0.08138420323895956,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,1/8,116/10899,0.0820656689635596,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,1/8,116/10899,0.0820656689635596,0.1252581263128015,0.08486938987921215,APP,1
R-HSA-373760,L1CAM interactions,1/8,119/10899,0.08410741279938505,0.12616111919907758,0.0854812180901191,CHL1,1
R-HSA-1630316,Glycosaminoglycan metabolism,1/8,124/10899,0.08750148948966763,0.12785952474581114,0.08663198288887385,B4GALT5,1
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),1/8,125/10899,0.08817898258331802,0.12785952474581114,0.08663198288887385,APP,1
R-HSA-114608,Platelet degranulation ,1/8,129/10899,0.09088455565313958,0.1296222351118548,0.08782631780113574,APP,1
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,1/8,134/10899,0.09425664191995142,0.13226335237154474,0.08961582253849372,APP,1
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,1/8,146/10899,0.10230503369915012,0.13997878510280704,0.0948434599607646,APP,1
R-HSA-8980692,RHOA GTPase cycle,1/8,147/10899,0.10297289938597298,0.13997878510280704,0.0948434599607646,DLC1,1
R-HSA-446652,Interleukin-1 family signaling,1/8,153/10899,0.10697097101991526,0.1427593441948859,0.09672744434257242,APP,1
R-HSA-9013148,CDC42 GTPase cycle,1/8,155/10899,0.10830019214784448,0.1427593441948859,0.09672744434257242,DLC1,1
R-HSA-9609507,Protein localization,1/8,163/10899,0.11359978117536007,0.14618595676323484,0.09904916610697098,APP,1
R-HSA-9658195,Leishmania infection,1/8,164/10899,0.11426028804482724,0.14618595676323484,0.09904916610697098,APP,1
R-HSA-168898,Toll-like Receptor Cascades,1/8,168/10899,0.11689801094490582,0.14739314423488126,0.09986710317184935,APP,1
R-HSA-9013149,RAC1 GTPase cycle,1/8,185/10899,0.1280318108897065,0.15688404996344316,0.1062977229032404,DLC1,1
R-HSA-948021,Transport to the Golgi and subsequent modification,1/8,185/10899,0.1280318108897065,0.15688404996344316,0.1062977229032404,B4GALT5,1
R-HSA-375276,Peptide ligand-binding receptors,1/8,201/10899,0.13839828388388098,0.16723125969302283,0.11330853651311894,APP,1
R-HSA-416476,G alpha (q) signalling events,1/8,216/10899,0.1480187498090364,0.17640590730665984,0.11952487367420386,APP,1
R-HSA-76002,"Platelet activation, signaling and aggregation",1/8,263/10899,0.17755700302429378,0.20874944950153457,0.14143943341906762,APP,1
R-HSA-3247509,Chromatin modifying enzymes,1/8,274/10899,0.18433936472008716,0.2110200622453629,0.14297790061391802,ARID5B,1
R-HSA-4839726,Chromatin organization,1/8,274/10899,0.18433936472008716,0.2110200622453629,0.14297790061391802,ARID5B,1
R-HSA-5684996,MAPK1/MAPK3 signaling,1/8,286/10899,0.1916824417276367,0.2165762653286285,0.14674253912163576,IL6ST,1
R-HSA-71387,Metabolism of carbohydrates,1/8,295/10899,0.1971517254030869,0.2199000014111354,0.1489945563100252,B4GALT5,1
R-HSA-1474244,Extracellular matrix organization,1/8,300/10899,0.2001762022373088,0.22031510347703706,0.14927581118831307,APP,1
R-HSA-446203,Asparagine N-linked glycosylation,1/8,304/10899,0.2025886008984249,0.22031510347703706,0.14927581118831307,B4GALT5,1
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,1/8,309/10899,0.20559514441702098,0.22082441437383737,0.14962089782135382,UBE2H,1
R-HSA-418594,G alpha (i) signalling events,1/8,318/10899,0.2109819343774858,0.22384668647367398,0.1516686562919025,APP,1
R-HSA-5683057,MAPK family signaling cascades,1/8,325/10899,0.21514953599533604,0.22551818833246065,0.15280119233657347,IL6ST,1
R-HSA-373076,Class A/1 (Rhodopsin-like receptors),1/8,335/10899,0.22106983639442346,0.2289651876942243,0.15513672729433226,APP,1
R-HSA-983169,Class I MHC mediated antigen processing & presentation,1/8,381/10899,0.24780286173359634,0.2536335173037986,0.1718509010164879,UBE2H,1
R-HSA-9012999,RHO GTPase cycle,1/8,449/10899,0.28585049123305395,0.28917433415436855,0.19593179325643847,DLC1,1
R-HSA-500792,GPCR ligand binding,1/8,467/10899,0.29563553709816814,0.29563553709816814,0.20030961981243092,APP,1
HALLMARK_ESTROGEN_RESPONSE_EARLY,HALLMARK_ESTROGEN_RESPONSE_EARLY,3/7,200/4383,0.00285880475689797,0.04574087611036752,0.039120486147024854,IL6ST/DLC1/UGCG,3
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,2/7,200/4383,0.037387854279815044,0.19940188949234688,0.17054108969740198,ARID5B/ARL4A,2
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,2/7,200/4383,0.037387854279815044,0.19940188949234688,0.17054108969740198,IL6ST/B4GALT5,2
HALLMARK_ANGIOGENESIS,HALLMARK_ANGIOGENESIS,1/7,36/4383,0.05613488003921541,0.21835377297508743,0.18674993741290372,APP,1
HALLMARK_APICAL_SURFACE,HALLMARK_APICAL_SURFACE,1/7,44/4383,0.06823555405471482,0.21835377297508743,0.18674993741290372,APP,1
HALLMARK_IL6_JAK_STAT3_SIGNALING,HALLMARK_IL6_JAK_STAT3_SIGNALING,1/7,87/4383,0.13102469852555276,0.2790333633363433,0.23864695548503048,IL6ST,1
HALLMARK_ANDROGEN_RESPONSE,HALLMARK_ANDROGEN_RESPONSE,1/7,100/4383,0.14927813593069883,0.2790333633363433,0.23864695548503048,ARID5B,1
HALLMARK_SPERMATOGENESIS,HALLMARK_SPERMATOGENESIS,1/7,135/4383,0.19679746950197985,0.2790333633363433,0.23864695548503048,ARL4A,1
HALLMARK_UV_RESPONSE_DN,HALLMARK_UV_RESPONSE_DN,1/7,144/4383,0.20864224140848786,0.2790333633363433,0.23864695548503048,DLC1,1
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,1/7,158/4383,0.22676980496790278,0.2790333633363433,0.23864695548503048,IL6ST,1
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,1/7,161/4383,0.23060762226811438,0.2790333633363433,0.23864695548503048,APP,1
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,1/7,199/4383,0.2778251357910607,0.2790333633363433,0.23864695548503048,ARL4A,1
HALLMARK_ADIPOGENESIS,HALLMARK_ADIPOGENESIS,1/7,200/4383,0.2790333633363433,0.2790333633363433,0.23864695548503048,ARL4A,1
HALLMARK_ESTROGEN_RESPONSE_LATE,HALLMARK_ESTROGEN_RESPONSE_LATE,1/7,200/4383,0.2790333633363433,0.2790333633363433,0.23864695548503048,IL6ST,1
HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,1/7,200/4383,0.2790333633363433,0.2790333633363433,0.23864695548503048,APP,1
HALLMARK_P53_PATHWAY,HALLMARK_P53_PATHWAY,1/7,200/4383,0.2790333633363433,0.2790333633363433,0.23864695548503048,APP,1
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,4/11,496/21728,7.793883276582171e-5,0.027630100955503216,0.013240720097455973,ARID5B/IL6ST/UBE2H/ARL4A,4
AMUNDSON_RESPONSE_TO_ARSENITE,AMUNDSON_RESPONSE_TO_ARSENITE,3/11,219/21728,1.5699388850327342e-4,0.027630100955503216,0.013240720097455973,IL6ST/UBE2H/DLC1,3
RIGGINS_TAMOXIFEN_RESISTANCE_DN,RIGGINS_TAMOXIFEN_RESISTANCE_DN,3/11,221/21728,1.6126518067414327e-4,0.027630100955503216,0.013240720097455973,ARID5B/IL6ST/UGCG,3
HALMOS_CEBPA_TARGETS_UP,HALMOS_CEBPA_TARGETS_UP,2/11,48/21728,2.5951614519636497e-4,0.02815704425010889,0.013493238489710178,UGCG/ARL4A,2
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,2/11,50/21728,2.816770499014258e-4,0.02815704425010889,0.013493238489710178,IL6ST/APP,2
SESTO_RESPONSE_TO_UV_C2,SESTO_RESPONSE_TO_UV_C2,2/11,54/21728,3.2868145039037614e-4,0.02815704425010889,0.013493238489710178,UBE2H/UGCG,2
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,3/11,336/21728,5.515029067985543e-4,0.035368463235852014,0.016949048529980283,ARID5B/UBE2H/DLC1,3
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,3/11,341/21728,5.757670540720171e-4,0.035368463235852014,0.016949048529980283,ARID5B/IL6ST/B4GALT5,3
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,2/11,78/21728,6.851915874851907e-4,0.035368463235852014,0.016949048529980283,ARID5B/DLC1,2
BHAT_ESR1_TARGETS_VIA_AKT1_DN,BHAT_ESR1_TARGETS_VIA_AKT1_DN,2/11,82/21728,7.569126373431365e-4,0.035368463235852014,0.016949048529980283,ARID5B/UBE2H,2
RADMACHER_AML_PROGNOSIS,RADMACHER_AML_PROGNOSIS,2/11,82/21728,7.569126373431365e-4,0.035368463235852014,0.016949048529980283,IL6ST/UGCG,2
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,2/11,88/21728,8.710219453592495e-4,0.03568890905967937,0.017102610526244056,ARID5B/UBE2H,2
HOOI_ST7_TARGETS_UP,HOOI_ST7_TARGETS_UP,2/11,93/21728,9.720714529873758e-4,0.03568890905967937,0.017102610526244056,IL6ST/UGCG,2
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,2/11,93/21728,9.720714529873758e-4,0.03568890905967937,0.017102610526244056,ARID5B/KBTBD2,2
BROWNE_HCMV_INFECTION_12HR_DN,BROWNE_HCMV_INFECTION_12HR_DN,2/11,100/21728,0.0011225945974255892,0.03686109186792521,0.017664336467529185,DLC1/UGCG,2
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,3/11,433/21728,0.0011511978472286515,0.03686109186792521,0.017664336467529185,IL6ST/KBTBD2/APP,3
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,3/11,451/21728,0.001294673081234948,0.03686109186792521,0.017664336467529185,IL6ST/KBTBD2/DPY19L1,3
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,3/11,463/21728,0.0013963598233868954,0.03686109186792521,0.017664336467529185,ARID5B/KBTBD2/APP,3
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,3/11,466/21728,0.0014225496664741768,0.03686109186792521,0.017664336467529185,ARID5B/DLC1/UGCG,3
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,2/11,115/21728,0.0014804412703534823,0.03686109186792521,0.017664336467529185,IL6ST/UGCG,2
SENESE_HDAC2_TARGETS_UP,SENESE_HDAC2_TARGETS_UP,2/11,116/21728,0.0015059979167829367,0.03686109186792521,0.017664336467529185,IL6ST/DPY19L1,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,2/11,141/21728,0.00221318113199343,0.05170795917475559,0.024779157171601084,IL6ST/APP,2
VANTVEER_BREAST_CANCER_ESR1_UP,VANTVEER_BREAST_CANCER_ESR1_UP,2/11,149/21728,0.0024669378688292826,0.05513069845992397,0.026419380380139686,IL6ST/UGCG,2
WP_MESODERMAL_COMMITMENT_PATHWAY,WP_MESODERMAL_COMMITMENT_PATHWAY,2/11,155/21728,0.002665894530154837,0.057094574520816094,0.027360496493694382,ARID5B/ARL4A,2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,2/11,159/21728,0.002802624852820369,0.057621966973986784,0.027613230128840687,ARL4A/APP,2
SMID_BREAST_CANCER_LUMINAL_B_UP,SMID_BREAST_CANCER_LUMINAL_B_UP,2/11,169/21728,0.003158692021884173,0.0608311928193522,0.02915113479362772,IL6ST/UGCG,2
ONDER_CDH1_TARGETS_1_DN,ONDER_CDH1_TARGETS_1_DN,2/11,170/21728,0.003195412852378423,0.0608311928193522,0.02915113479362772,IL6ST/UGCG,2
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,2/11,179/21728,0.0035349630647500043,0.06265417294074146,0.030024731657041778,UGCG/B4GALT5,2
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,2/11,179/21728,0.0035349630647500043,0.06265417294074146,0.030024731657041778,DLC1/ARL4A,2
WU_CELL_MIGRATION,WU_CELL_MIGRATION,2/11,183/21728,0.0036910892618069184,0.0632406626856252,0.030305785517993646,ARID5B/UGCG,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,2/11,194/21728,0.004136868651647535,0.06349065373293347,0.030425584627291485,DLC1/ARL4A,2
YAGI_AML_FAB_MARKERS,YAGI_AML_FAB_MARKERS,2/11,194/21728,0.004136868651647535,0.06349065373293347,0.030425584627291485,ARID5B/DLC1,2
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,2/11,197/21728,0.004262605715326911,0.06349065373293347,0.030425584627291485,DLC1/DPY19L1,2
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,2/11,198/21728,0.004304912608421551,0.06349065373293347,0.030425584627291485,ARID5B/ARL4A,2
WANG_TUMOR_INVASIVENESS_DN,WANG_TUMOR_INVASIVENESS_DN,2/11,211/21728,0.004872764635428408,0.06349065373293347,0.030425584627291485,UBE2H/KBTBD2,2
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN,1/11,10/21728,0.0050521182061631364,0.06349065373293347,0.030425584627291485,UGCG,1
REACTOME_MAPK3_ERK1_ACTIVATION,REACTOME_MAPK3_ERK1_ACTIVATION,1/11,10/21728,0.0050521182061631364,0.06349065373293347,0.030425584627291485,IL6ST,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_INVOLUTION_STAGE_4_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_INVOLUTION_STAGE_4_OF_4,1/11,10/21728,0.0050521182061631364,0.06349065373293347,0.030425584627291485,IL6ST,1
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,2/11,216/21728,0.005099953241036861,0.06349065373293347,0.030425584627291485,ARID5B/APP,2
REACTOME_INTERLEUKIN_27_SIGNALING,REACTOME_INTERLEUKIN_27_SIGNALING,1/11,11/21728,0.005556051657665373,0.06349065373293347,0.030425584627291485,IL6ST,1
REACTOME_INTERLEUKIN_6_SIGNALING,REACTOME_INTERLEUKIN_6_SIGNALING,1/11,11/21728,0.005556051657665373,0.06349065373293347,0.030425584627291485,IL6ST,1
WP_INCLUSION_BODY_MYOSITIS,WP_INCLUSION_BODY_MYOSITIS,1/11,11/21728,0.005556051657665373,0.06349065373293347,0.030425584627291485,APP,1
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,2/11,232/21728,0.005859424014857152,0.06349065373293347,0.030425584627291485,DLC1/UGCG,2
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,2/11,236/21728,0.006056965186562109,0.06349065373293347,0.030425584627291485,UBE2H/B4GALT5,2
REACTOME_INTERLEUKIN_35_SIGNALLING,REACTOME_INTERLEUKIN_35_SIGNALLING,1/11,12/21728,0.006059753063557771,0.06349065373293347,0.030425584627291485,IL6ST,1
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,2/11,238/21728,0.006156879323168654,0.06349065373293347,0.030425584627291485,DLC1/APP,2
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,2/11,243/21728,0.006409989167646444,0.06349065373293347,0.030425584627291485,IL6ST/DPY19L1,2
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,2/11,244/21728,0.006461179700493027,0.06349065373293347,0.030425584627291485,ARID5B/ARL4A,2
GRANDVAUX_IRF3_TARGETS_UP,GRANDVAUX_IRF3_TARGETS_UP,1/11,13/21728,0.006563222520009071,0.06349065373293347,0.030425584627291485,B4GALT5,1
REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING,REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING,1/11,13/21728,0.006563222520009071,0.06349065373293347,0.030425584627291485,APP,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,2/11,247/21728,0.006615885392296371,0.06349065373293347,0.030425584627291485,ARID5B/APP,2
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,2/11,250/21728,0.006772288689630252,0.06349065373293347,0.030425584627291485,UGCG/APP,2
PLASARI_TGFB1_TARGETS_10HR_DN,PLASARI_TGFB1_TARGETS_10HR_DN,2/11,254/21728,0.006983459297278946,0.06349065373293347,0.030425584627291485,ARID5B/IL6ST,2
BIOCARTA_PLATELETAPP_PATHWAY,BIOCARTA_PLATELETAPP_PATHWAY,1/11,14/21728,0.007066460123153595,0.06349065373293347,0.030425584627291485,APP,1
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,2/11,257/21728,0.007143806040924114,0.06349065373293347,0.030425584627291485,ARID5B/DLC1,2
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,2/11,258/21728,0.007197629069543997,0.06349065373293347,0.030425584627291485,ARID5B/DPY19L1,2
MATZUK_OVULATION,MATZUK_OVULATION,1/11,15/21728,0.007569465969089362,0.06349065373293347,0.030425584627291485,IL6ST,1
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION,1/11,15/21728,0.007569465969089362,0.06349065373293347,0.030425584627291485,B4GALT5,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP,1/11,15/21728,0.007569465969089362,0.06349065373293347,0.030425584627291485,ARID5B,1
WP_FOXP3_IN_COVID19,WP_FOXP3_IN_COVID19,1/11,15/21728,0.007569465969089362,0.06349065373293347,0.030425584627291485,IL6ST,1
REACTOME_THE_NLRP3_INFLAMMASOME,REACTOME_THE_NLRP3_INFLAMMASOME,1/11,16/21728,0.00807224015387853,0.06349065373293347,0.030425584627291485,APP,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,2/11,281/21728,0.008486772320527303,0.06349065373293347,0.030425584627291485,UGCG/APP,2
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,1/11,17/21728,0.008574782773550171,0.06349065373293347,0.030425584627291485,IL6ST,1
REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,1/11,17/21728,0.008574782773550171,0.06349065373293347,0.030425584627291485,IL6ST,1
WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,1/11,17/21728,0.008574782773550171,0.06349065373293347,0.030425584627291485,IL6ST,1
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,2/11,289/21728,0.008957959554062018,0.06349065373293347,0.030425584627291485,ARID5B/UGCG,2
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,2/11,289/21728,0.008957959554062018,0.06349065373293347,0.030425584627291485,ARID5B/UGCG,2
GRADE_COLON_AND_RECTAL_CANCER_UP,GRADE_COLON_AND_RECTAL_CANCER_UP,2/11,290/21728,0.009017677074018423,0.06349065373293347,0.030425584627291485,KBTBD2/DPY19L1,2
CHEN_PDGF_TARGETS,CHEN_PDGF_TARGETS,1/11,18/21728,0.009077093924095947,0.06349065373293347,0.030425584627291485,ARID5B,1
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,1/11,18/21728,0.009077093924095947,0.06349065373293347,0.030425584627291485,UBE2H,1
WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,1/11,18/21728,0.009077093924095947,0.06349065373293347,0.030425584627291485,IL6ST,1
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,2/11,300/21728,0.009624806518749576,0.06349065373293347,0.030425584627291485,ARID5B/KBTBD2,2
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,2/11,300/21728,0.009624806518749576,0.06349065373293347,0.030425584627291485,UBE2H/UGCG,2
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,1/11,20/21728,0.010081022201600232,0.06349065373293347,0.030425584627291485,IL6ST,1
WP_METABOLISM_OF_SPINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,WP_METABOLISM_OF_SPINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,1/11,20/21728,0.010081022201600232,0.06349065373293347,0.030425584627291485,UGCG,1
BIOCARTA_IL6_PATHWAY,BIOCARTA_IL6_PATHWAY,1/11,21/21728,0.010582639520366643,0.06349065373293347,0.030425584627291485,IL6ST,1
OUYANG_PROSTATE_CANCER_PROGRESSION_DN,OUYANG_PROSTATE_CANCER_PROGRESSION_DN,1/11,21/21728,0.010582639520366643,0.06349065373293347,0.030425584627291485,ARL4A,1
REACTOME_INFLAMMASOMES,REACTOME_INFLAMMASOMES,1/11,21/21728,0.010582639520366643,0.06349065373293347,0.030425584627291485,APP,1
WOTTON_RUNX_TARGETS_UP,WOTTON_RUNX_TARGETS_UP,1/11,21/21728,0.010582639520366643,0.06349065373293347,0.030425584627291485,UGCG,1
KANG_FLUOROURACIL_RESISTANCE_UP,KANG_FLUOROURACIL_RESISTANCE_UP,1/11,22/21728,0.01108402575362244,0.06349065373293347,0.030425584627291485,ARID5B,1
KANNAN_TP53_TARGETS_DN,KANNAN_TP53_TARGETS_DN,1/11,22/21728,0.01108402575362244,0.06349065373293347,0.030425584627291485,ARL4A,1
REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE,REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE,1/11,22/21728,0.01108402575362244,0.06349065373293347,0.030425584627291485,APP,1
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,2/11,329/21728,0.011486600637904304,0.06349065373293347,0.030425584627291485,IL6ST/UGCG,2
BIOCARTA_HER2_PATHWAY,BIOCARTA_HER2_PATHWAY,1/11,23/21728,0.011585180997182087,0.06349065373293347,0.030425584627291485,IL6ST,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,1/11,23/21728,0.011585180997182087,0.06349065373293347,0.030425584627291485,B4GALT5,1
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,1/11,23/21728,0.011585180997182087,0.06349065373293347,0.030425584627291485,DPY19L1,1
REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,1/11,23/21728,0.011585180997182087,0.06349065373293347,0.030425584627291485,IL6ST,1
ZIRN_TRETINOIN_RESPONSE_WT1_UP,ZIRN_TRETINOIN_RESPONSE_WT1_UP,1/11,23/21728,0.011585180997182087,0.06349065373293347,0.030425584627291485,DLC1,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN,1/11,24/21728,0.012086105346826304,0.06349065373293347,0.030425584627291485,B4GALT5,1
HASLINGER_B_CLL_WITH_13Q14_DELETION,HASLINGER_B_CLL_WITH_13Q14_DELETION,1/11,24/21728,0.012086105346826304,0.06349065373293347,0.030425584627291485,ARL4A,1
MAEKAWA_ATF2_TARGETS,MAEKAWA_ATF2_TARGETS,1/11,24/21728,0.012086105346826304,0.06349065373293347,0.030425584627291485,CHL1,1
REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,1/11,24/21728,0.012086105346826304,0.06349065373293347,0.030425584627291485,IL6ST,1
RUAN_RESPONSE_TO_TROGLITAZONE_UP,RUAN_RESPONSE_TO_TROGLITAZONE_UP,1/11,24/21728,0.012086105346826304,0.06349065373293347,0.030425584627291485,ARL4A,1
WP_SPHINGOLIPID_METABOLISM_OVERVIEW,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,1/11,24/21728,0.012086105346826304,0.06349065373293347,0.030425584627291485,UGCG,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,2/11,341/21728,0.012300309602708923,0.06349065373293347,0.030425584627291485,IL6ST/B4GALT5,2
REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,1/11,25/21728,0.012586798898300056,0.06349065373293347,0.030425584627291485,APP,1
REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION,REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION,1/11,25/21728,0.012586798898300056,0.06349065373293347,0.030425584627291485,APP,1
WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,1/11,25/21728,0.012586798898300056,0.06349065373293347,0.030425584627291485,IL6ST,1
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,1/11,25/21728,0.012586798898300056,0.06349065373293347,0.030425584627291485,IL6ST,1
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,1/11,26/21728,0.01308726174731245,0.06349065373293347,0.030425584627291485,APP,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,1/11,26/21728,0.01308726174731245,0.06349065373293347,0.030425584627291485,DPY19L1,1
PID_IL27_PATHWAY,PID_IL27_PATHWAY,1/11,26/21728,0.01308726174731245,0.06349065373293347,0.030425584627291485,IL6ST,1
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI,1/11,26/21728,0.01308726174731245,0.06349065373293347,0.030425584627291485,B4GALT5,1
REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,1/11,26/21728,0.01308726174731245,0.06349065373293347,0.030425584627291485,APP,1
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,2/11,357/21728,0.013424010956321493,0.06349065373293347,0.030425584627291485,IL6ST/APP,2
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,2/11,359/21728,0.013567559354933348,0.06349065373293347,0.030425584627291485,UGCG/ARL4A,2
AKL_HTLV1_INFECTION_UP,AKL_HTLV1_INFECTION_UP,1/11,27/21728,0.01358749398953829,0.06349065373293347,0.030425584627291485,APP,1
PID_GLYPICAN_1PATHWAY,PID_GLYPICAN_1PATHWAY,1/11,27/21728,0.01358749398953829,0.06349065373293347,0.030425584627291485,APP,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_7,SHIN_B_CELL_LYMPHOMA_CLUSTER_7,1/11,27/21728,0.01358749398953829,0.06349065373293347,0.030425584627291485,IL6ST,1
WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,1/11,27/21728,0.01358749398953829,0.06349065373293347,0.030425584627291485,UGCG,1
REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,1/11,28/21728,0.014087495720615961,0.06407940531324428,0.030707722390536887,B4GALT5,1
WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,1/11,28/21728,0.014087495720615961,0.06407940531324428,0.030707722390536887,IL6ST,1
WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,1/11,28/21728,0.014087495720615961,0.06407940531324428,0.030707722390536887,UGCG,1
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,2/11,371/21728,0.01444311717010448,0.06512072127573423,0.031206735159782534,ARID5B/APP,2
YANAGIHARA_ESX1_TARGETS,YANAGIHARA_ESX1_TARGETS,1/11,29/21728,0.01458726703614921,0.06516486830501837,0.03122789101653553,IL6ST,1
KEGG_O_GLYCAN_BIOSYNTHESIS,KEGG_O_GLYCAN_BIOSYNTHESIS,1/11,30/21728,0.015086808031706589,0.06516486830501837,0.03122789101653553,B4GALT5,1
LY_AGING_PREMATURE_DN,LY_AGING_PREMATURE_DN,1/11,30/21728,0.015086808031706589,0.06516486830501837,0.03122789101653553,UGCG,1
REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES,REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES,1/11,30/21728,0.015086808031706589,0.06516486830501837,0.03122789101653553,UBE2H,1
WP_SPHINGOLIPID_PATHWAY,WP_SPHINGOLIPID_PATHWAY,1/11,30/21728,0.015086808031706589,0.06516486830501837,0.03122789101653553,UGCG,1
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,1/11,31/21728,0.015586118802821347,0.06566610708729649,0.03146809145694733,CHL1,1
DANG_MYC_TARGETS_DN,DANG_MYC_TARGETS_DN,1/11,31/21728,0.015586118802821347,0.06566610708729649,0.03146809145694733,APP,1
SIMBULAN_PARP1_TARGETS_UP,SIMBULAN_PARP1_TARGETS_UP,1/11,31/21728,0.015586118802821347,0.06566610708729649,0.03146809145694733,APP,1
MODY_HIPPOCAMPUS_NEONATAL,MODY_HIPPOCAMPUS_NEONATAL,1/11,32/21728,0.01608519944499176,0.06597495134577361,0.031616093825334896,CHL1,1
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX,REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX,1/11,32/21728,0.01608519944499176,0.06597495134577361,0.031616093825334896,APP,1
YANG_BREAST_CANCER_ESR1_LASER_UP,YANG_BREAST_CANCER_ESR1_LASER_UP,1/11,32/21728,0.01608519944499176,0.06597495134577361,0.031616093825334896,UGCG,1
WEIGEL_OXIDATIVE_STRESS_RESPONSE,WEIGEL_OXIDATIVE_STRESS_RESPONSE,1/11,33/21728,0.0165840500536798,0.06597495134577361,0.031616093825334896,APP,1
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,2/11,400/21728,0.01665869037893209,0.06597495134577361,0.031616093825334896,IL6ST/UBE2H,2
BILANGES_SERUM_RESPONSE_TRANSLATION,BILANGES_SERUM_RESPONSE_TRANSLATION,1/11,34/21728,0.017082670724314686,0.06597495134577361,0.031616093825334896,ARID5B,1
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,1/11,34/21728,0.017082670724314686,0.06597495134577361,0.031616093825334896,DLC1,1
PETRETTO_CARDIAC_HYPERTROPHY,PETRETTO_CARDIAC_HYPERTROPHY,1/11,34/21728,0.017082670724314686,0.06597495134577361,0.031616093825334896,ARID5B,1
PID_IL2_PI3K_PATHWAY,PID_IL2_PI3K_PATHWAY,1/11,34/21728,0.017082670724314686,0.06597495134577361,0.031616093825334896,UGCG,1
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,1/11,34/21728,0.017082670724314686,0.06597495134577361,0.031616093825334896,B4GALT5,1
VALK_AML_CLUSTER_3,VALK_AML_CLUSTER_3,1/11,34/21728,0.017082670724314686,0.06597495134577361,0.031616093825334896,IL6ST,1
GENTILE_UV_RESPONSE_CLUSTER_D6,GENTILE_UV_RESPONSE_CLUSTER_D6,1/11,35/21728,0.01758106155228678,0.06597495134577361,0.031616093825334896,UGCG,1
REACTOME_LYSOSOME_VESICLE_BIOGENESIS,REACTOME_LYSOSOME_VESICLE_BIOGENESIS,1/11,35/21728,0.01758106155228678,0.06597495134577361,0.031616093825334896,APP,1
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,2/11,414/21728,0.01777786997562485,0.06597495134577361,0.031616093825334896,ARL4A/B4GALT5,2
SUBTIL_PROGESTIN_TARGETS,SUBTIL_PROGESTIN_TARGETS,1/11,36/21728,0.01807922263295436,0.06597495134577361,0.031616093825334896,IL6ST,1
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,1/11,36/21728,0.01807922263295436,0.06597495134577361,0.031616093825334896,ARID5B,1
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,2/11,422/21728,0.01843166980082214,0.06597495134577361,0.031616093825334896,IL6ST/B4GALT5,2
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,1/11,37/21728,0.018577154061639845,0.06597495134577361,0.031616093825334896,IL6ST,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,1/11,37/21728,0.018577154061639845,0.06597495134577361,0.031616093825334896,UGCG,1
VALK_AML_WITH_CEBPA,VALK_AML_WITH_CEBPA,1/11,37/21728,0.018577154061639845,0.06597495134577361,0.031616093825334896,DLC1,1
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,2/11,428/21728,0.018928769879196918,0.06597495134577361,0.031616093825334896,IL6ST/APP,2
VALK_AML_CLUSTER_11,VALK_AML_CLUSTER_11,1/11,38/21728,0.01907485593362923,0.06597495134577361,0.031616093825334896,APP,1
WEINMANN_ADAPTATION_TO_HYPOXIA_DN,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,1/11,38/21728,0.01907485593362923,0.06597495134577361,0.031616093825334896,UGCG,1
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,2/11,433/21728,0.019347413275271088,0.06597495134577361,0.031616093825334896,UGCG/B4GALT5,2
AMIT_EGF_RESPONSE_60_MCF10A,AMIT_EGF_RESPONSE_60_MCF10A,1/11,39/21728,0.019572328344174217,0.06597495134577361,0.031616093825334896,DLC1,1
KEGG_SPHINGOLIPID_METABOLISM,KEGG_SPHINGOLIPID_METABOLISM,1/11,39/21728,0.019572328344174217,0.06597495134577361,0.031616093825334896,UGCG,1
SESTO_RESPONSE_TO_UV_C6,SESTO_RESPONSE_TO_UV_C6,1/11,39/21728,0.019572328344174217,0.06597495134577361,0.031616093825334896,ARL4A,1
SPIRA_SMOKERS_LUNG_CANCER_UP,SPIRA_SMOKERS_LUNG_CANCER_UP,1/11,39/21728,0.019572328344174217,0.06597495134577361,0.031616093825334896,UGCG,1
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,2/11,437/21728,0.019685190005074123,0.06597495134577361,0.031616093825334896,ARID5B/UGCG,2
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,2/11,438/21728,0.019770030430995726,0.06597495134577361,0.031616093825334896,UGCG/APP,2
KRASNOSELSKAYA_ILF3_TARGETS_UP,KRASNOSELSKAYA_ILF3_TARGETS_UP,1/11,40/21728,0.020069571388492524,0.06597495134577361,0.031616093825334896,IL6ST,1
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,2/11,445/21728,0.02036833446937615,0.06597495134577361,0.031616093825334896,ARID5B/UBE2H,2
LEE_AGING_MUSCLE_DN,LEE_AGING_MUSCLE_DN,1/11,41/21728,0.020566585161764794,0.06597495134577361,0.031616093825334896,IL6ST,1
VALK_AML_WITH_FLT3_ITD,VALK_AML_WITH_FLT3_ITD,1/11,41/21728,0.020566585161764794,0.06597495134577361,0.031616093825334896,APP,1
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,2/11,453/21728,0.02106153614757497,0.06597495134577361,0.031616093825334896,ARID5B/B4GALT5,2
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER,MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER,1/11,42/21728,0.02106336975913714,0.06597495134577361,0.031616093825334896,CHL1,1
WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,1/11,42/21728,0.02106336975913714,0.06597495134577361,0.031616093825334896,CHL1,1
ULE_SPLICING_VIA_NOVA2,ULE_SPLICING_VIA_NOVA2,1/11,43/21728,0.021559925275722036,0.06597495134577361,0.031616093825334896,CHL1,1
WP_IL6_SIGNALING_PATHWAY,WP_IL6_SIGNALING_PATHWAY,1/11,43/21728,0.021559925275722036,0.06597495134577361,0.031616093825334896,IL6ST,1
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,2/11,463/21728,0.02194206448607117,0.06597495134577361,0.031616093825334896,IL6ST/APP,2
CORONEL_RFX7_DIRECT_TARGETS_UP,CORONEL_RFX7_DIRECT_TARGETS_UP,1/11,44/21728,0.022056251806594318,0.06597495134577361,0.031616093825334896,UBE2H,1
NAKAMURA_METASTASIS_MODEL_DN,NAKAMURA_METASTASIS_MODEL_DN,1/11,44/21728,0.022056251806594318,0.06597495134577361,0.031616093825334896,UGCG,1
WP_INTERLEUKIN11_SIGNALING_PATHWAY,WP_INTERLEUKIN11_SIGNALING_PATHWAY,1/11,44/21728,0.022056251806594318,0.06597495134577361,0.031616093825334896,IL6ST,1
CHENG_RESPONSE_TO_NICKEL_ACETATE,CHENG_RESPONSE_TO_NICKEL_ACETATE,1/11,45/21728,0.02255234944679574,0.06597495134577361,0.031616093825334896,APP,1
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,1/11,45/21728,0.02255234944679574,0.06597495134577361,0.031616093825334896,IL6ST,1
REACTOME_GLYCOSPHINGOLIPID_METABOLISM,REACTOME_GLYCOSPHINGOLIPID_METABOLISM,1/11,45/21728,0.02255234944679574,0.06597495134577361,0.031616093825334896,UGCG,1
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,1/11,45/21728,0.02255234944679574,0.06597495134577361,0.031616093825334896,ARL4A,1
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,2/11,472/21728,0.022747750363273027,0.06597495134577361,0.031616093825334896,DLC1/ARL4A,2
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,1/11,46/21728,0.023048218291331746,0.06597495134577361,0.031616093825334896,APP,1
KHETCHOUMIAN_TRIM24_TARGETS_UP,KHETCHOUMIAN_TRIM24_TARGETS_UP,1/11,46/21728,0.023048218291331746,0.06597495134577361,0.031616093825334896,APP,1
MARCHINI_TRABECTEDIN_RESISTANCE_DN,MARCHINI_TRABECTEDIN_RESISTANCE_DN,1/11,46/21728,0.023048218291331746,0.06597495134577361,0.031616093825334896,DLC1,1
NUTT_GBM_VS_AO_GLIOMA_UP,NUTT_GBM_VS_AO_GLIOMA_UP,1/11,46/21728,0.023048218291331746,0.06597495134577361,0.031616093825334896,CHL1,1
PID_RHOA_REG_PATHWAY,PID_RHOA_REG_PATHWAY,1/11,46/21728,0.023048218291331746,0.06597495134577361,0.031616093825334896,DLC1,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_3,RASHI_RESPONSE_TO_IONIZING_RADIATION_3,1/11,46/21728,0.023048218291331746,0.06597495134577361,0.031616093825334896,UBE2H,1
SILIGAN_BOUND_BY_EWS_FLT1_FUSION,SILIGAN_BOUND_BY_EWS_FLT1_FUSION,1/11,46/21728,0.023048218291331746,0.06597495134577361,0.031616093825334896,CHL1,1
AMIT_EGF_RESPONSE_60_HELA,AMIT_EGF_RESPONSE_60_HELA,1/11,47/21728,0.023543858435174814,0.06597495134577361,0.031616093825334896,UGCG,1
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,1/11,47/21728,0.023543858435174814,0.06597495134577361,0.031616093825334896,ARID5B,1
PID_IL6_7_PATHWAY,PID_IL6_7_PATHWAY,1/11,47/21728,0.023543858435174814,0.06597495134577361,0.031616093825334896,IL6ST,1
TSENG_ADIPOGENIC_POTENTIAL_DN,TSENG_ADIPOGENIC_POTENTIAL_DN,1/11,47/21728,0.023543858435174814,0.06597495134577361,0.031616093825334896,IL6ST,1
ZHAN_MULTIPLE_MYELOMA_CD1_DN,ZHAN_MULTIPLE_MYELOMA_CD1_DN,1/11,47/21728,0.023543858435174814,0.06597495134577361,0.031616093825334896,UGCG,1
ZHAN_MULTIPLE_MYELOMA_LB_UP,ZHAN_MULTIPLE_MYELOMA_LB_UP,1/11,47/21728,0.023543858435174814,0.06597495134577361,0.031616093825334896,ARID5B,1
APRELIKOVA_BRCA1_TARGETS,APRELIKOVA_BRCA1_TARGETS,1/11,48/21728,0.024039269973259336,0.06597495134577361,0.031616093825334896,APP,1
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,1/11,48/21728,0.024039269973259336,0.06597495134577361,0.031616093825334896,UGCG,1
DAUER_STAT3_TARGETS_UP,DAUER_STAT3_TARGETS_UP,1/11,48/21728,0.024039269973259336,0.06597495134577361,0.031616093825334896,UGCG,1
PARK_APL_PATHOGENESIS_DN,PARK_APL_PATHOGENESIS_DN,1/11,48/21728,0.024039269973259336,0.06597495134577361,0.031616093825334896,APP,1
ZHAN_MULTIPLE_MYELOMA_PR_DN,ZHAN_MULTIPLE_MYELOMA_PR_DN,1/11,49/21728,0.024534453000486844,0.06597495134577361,0.031616093825334896,ARID5B,1
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,2/11,495/21728,0.024862822683511074,0.06597495134577361,0.031616093825334896,IL6ST/KBTBD2,2
BROWNE_HCMV_INFECTION_4HR_UP,BROWNE_HCMV_INFECTION_4HR_UP,1/11,50/21728,0.025029407611723453,0.06597495134577361,0.031616093825334896,IL6ST,1
BURTON_ADIPOGENESIS_7,BURTON_ADIPOGENESIS_7,1/11,50/21728,0.025029407611723453,0.06597495134577361,0.031616093825334896,IL6ST,1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,1/11,50/21728,0.025029407611723453,0.06597495134577361,0.031616093825334896,DPY19L1,1
REACTOME_HDMS_DEMETHYLATE_HISTONES,REACTOME_HDMS_DEMETHYLATE_HISTONES,1/11,50/21728,0.025029407611723453,0.06597495134577361,0.031616093825334896,ARID5B,1
WARTERS_IR_RESPONSE_5GY,WARTERS_IR_RESPONSE_5GY,1/11,50/21728,0.025029407611723453,0.06597495134577361,0.031616093825334896,APP,1
ZHU_CMV_8_HR_DN,ZHU_CMV_8_HR_DN,1/11,50/21728,0.025029407611723453,0.06597495134577361,0.031616093825334896,IL6ST,1
FRASOR_TAMOXIFEN_RESPONSE_UP,FRASOR_TAMOXIFEN_RESPONSE_UP,1/11,51/21728,0.02552413390179964,0.06641899095466504,0.031828883644054104,KBTBD2,1
PID_CASPASE_PATHWAY,PID_CASPASE_PATHWAY,1/11,51/21728,0.02552413390179964,0.06641899095466504,0.031828883644054104,APP,1
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,1/11,52/21728,0.02601863196551124,0.06641899095466504,0.031828883644054104,IL6ST,1
BROWNE_HCMV_INFECTION_1HR_UP,BROWNE_HCMV_INFECTION_1HR_UP,1/11,52/21728,0.02601863196551124,0.06641899095466504,0.031828883644054104,IL6ST,1
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,1/11,52/21728,0.02601863196551124,0.06641899095466504,0.031828883644054104,DPY19L1,1
KENNY_CTNNB1_TARGETS_DN,KENNY_CTNNB1_TARGETS_DN,1/11,52/21728,0.02601863196551124,0.06641899095466504,0.031828883644054104,IL6ST,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,1/11,53/21728,0.026512901897619345,0.06641899095466504,0.031828883644054104,UGCG,1
BECKER_TAMOXIFEN_RESISTANCE_UP,BECKER_TAMOXIFEN_RESISTANCE_UP,1/11,54/21728,0.02700694379285018,0.06641899095466504,0.031828883644054104,ARL4A,1
GENTILE_UV_RESPONSE_CLUSTER_D4,GENTILE_UV_RESPONSE_CLUSTER_D4,1/11,54/21728,0.02700694379285018,0.06641899095466504,0.031828883644054104,ARID5B,1
HENDRICKS_SMARCA4_TARGETS_UP,HENDRICKS_SMARCA4_TARGETS_UP,1/11,54/21728,0.02700694379285018,0.06641899095466504,0.031828883644054104,UBE2H,1
IKEDA_MIR1_TARGETS_UP,IKEDA_MIR1_TARGETS_UP,1/11,54/21728,0.02700694379285018,0.06641899095466504,0.031828883644054104,UBE2H,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,1/11,54/21728,0.02700694379285018,0.06641899095466504,0.031828883644054104,ARID5B,1
WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,1/11,54/21728,0.02700694379285018,0.06641899095466504,0.031828883644054104,APP,1
WP_COPPER_HOMEOSTASIS,WP_COPPER_HOMEOSTASIS,1/11,54/21728,0.02700694379285018,0.06641899095466504,0.031828883644054104,APP,1
LY_AGING_OLD_DN,LY_AGING_OLD_DN,1/11,56/21728,0.027994343851407977,0.06779018024473168,0.03248597619755726,UGCG,1
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,1/11,56/21728,0.027994343851407977,0.06779018024473168,0.03248597619755726,APP,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,1/11,56/21728,0.027994343851407977,0.06779018024473168,0.03248597619755726,UGCG,1
BYSTROEM_CORRELATED_WITH_IL5_DN,BYSTROEM_CORRELATED_WITH_IL5_DN,1/11,57/21728,0.028487702204011756,0.06779018024473168,0.03248597619755726,IL6ST,1
NAGASHIMA_EGF_SIGNALING_UP,NAGASHIMA_EGF_SIGNALING_UP,1/11,57/21728,0.028487702204011756,0.06779018024473168,0.03248597619755726,KBTBD2,1
PID_SHP2_PATHWAY,PID_SHP2_PATHWAY,1/11,57/21728,0.028487702204011756,0.06779018024473168,0.03248597619755726,IL6ST,1
REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,1/11,57/21728,0.028487702204011756,0.06779018024473168,0.03248597619755726,IL6ST,1
HUPER_BREAST_BASAL_VS_LUMINAL_DN,HUPER_BREAST_BASAL_VS_LUMINAL_DN,1/11,58/21728,0.028980832898292674,0.06833095463175429,0.0327451226373756,UGCG,1
KOHOUTEK_CCNT2_TARGETS,KOHOUTEK_CCNT2_TARGETS,1/11,58/21728,0.028980832898292674,0.06833095463175429,0.0327451226373756,ARL4A,1
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,1/11,59/21728,0.02947373602880099,0.06854977519820683,0.032849984428385,KBTBD2,1
REACTOME_RHOQ_GTPASE_CYCLE,REACTOME_RHOQ_GTPASE_CYCLE,1/11,59/21728,0.02947373602880099,0.06854977519820683,0.032849984428385,DLC1,1
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,1/11,59/21728,0.02947373602880099,0.06854977519820683,0.032849984428385,IL6ST,1
BERNARD_PPAPDC1B_TARGETS_DN,BERNARD_PPAPDC1B_TARGETS_DN,1/11,60/21728,0.029966411690053762,0.06938169193102538,0.033248650239319964,IL6ST,1
LEE_LIVER_CANCER_MYC_TGFA_UP,LEE_LIVER_CANCER_MYC_TGFA_UP,1/11,61/21728,0.03045885997653186,0.07020562344366536,0.033643489424160754,APP,1
REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,1/11,62/21728,0.0309510809826824,0.07102167689776229,0.03403455333622031,B4GALT5,1
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,1/11,63/21728,0.03144307480291597,0.07119709448765994,0.034118615830662356,DPY19L1,1
LINDSTEDT_DENDRITIC_CELL_MATURATION_C,LINDSTEDT_DENDRITIC_CELL_MATURATION_C,1/11,63/21728,0.03144307480291597,0.07119709448765994,0.034118615830662356,UGCG,1
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,1/11,63/21728,0.03144307480291597,0.07119709448765994,0.034118615830662356,UGCG,1
DELPUECH_FOXO3_TARGETS_UP,DELPUECH_FOXO3_TARGETS_UP,1/11,65/21728,0.032426381263107484,0.07292971880664363,0.03494891296488759,UBE2H,1
GAJATE_RESPONSE_TO_TRABECTEDIN_UP,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,1/11,66/21728,0.03291769409171463,0.07292971880664363,0.03494891296488759,UGCG,1
SWEET_KRAS_TARGETS_DN,SWEET_KRAS_TARGETS_DN,1/11,66/21728,0.03291769409171463,0.07292971880664363,0.03494891296488759,APP,1
WP_ONCOSTATIN_M_SIGNALING_PATHWAY,WP_ONCOSTATIN_M_SIGNALING_PATHWAY,1/11,66/21728,0.03291769409171463,0.07292971880664363,0.03494891296488759,IL6ST,1
WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,1/11,66/21728,0.03291769409171463,0.07292971880664363,0.03494891296488759,ARID5B,1
PID_P75_NTR_PATHWAY,PID_P75_NTR_PATHWAY,1/11,68/21728,0.03389963941731067,0.07478289553861667,0.03583698045471288,APP,1
REACTOME_RHOB_GTPASE_CYCLE,REACTOME_RHOB_GTPASE_CYCLE,1/11,70/21728,0.034880678262160236,0.07629220692234195,0.03656026299370883,DLC1,1
ROSS_AML_OF_FAB_M7_TYPE,ROSS_AML_OF_FAB_M7_TYPE,1/11,70/21728,0.034880678262160236,0.07629220692234195,0.03656026299370883,DLC1,1
RAGHAVACHARI_PLATELET_SPECIFIC_GENES,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,1/11,71/21728,0.03537085798970263,0.07671148104095846,0.036761184852722256,APP,1
SESTO_RESPONSE_TO_UV_C8,SESTO_RESPONSE_TO_UV_C8,1/11,71/21728,0.03537085798970263,0.07671148104095846,0.036761184852722256,APP,1
LIN_MELANOMA_COPY_NUMBER_UP,LIN_MELANOMA_COPY_NUMBER_UP,1/11,72/21728,0.03586081137946662,0.07680190437102434,0.03680451694208416,ARL4A,1
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,1/11,72/21728,0.03586081137946662,0.07680190437102434,0.03680451694208416,APP,1
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,1/11,72/21728,0.03586081137946662,0.07680190437102434,0.03680451694208416,CHL1,1
CAMPS_COLON_CANCER_COPY_NUMBER_DN,CAMPS_COLON_CANCER_COPY_NUMBER_DN,1/11,74/21728,0.0368400395218772,0.07792502186932049,0.0373427301196416,APP,1
REACTOME_RHOC_GTPASE_CYCLE,REACTOME_RHOC_GTPASE_CYCLE,1/11,74/21728,0.0368400395218772,0.07792502186932049,0.0373427301196416,DLC1,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,1/11,74/21728,0.0368400395218772,0.07792502186932049,0.0373427301196416,UGCG,1
REACTOME_ECM_PROTEOGLYCANS,REACTOME_ECM_PROTEOGLYCANS,1/11,76/21728,0.03781836344148337,0.0786834760794927,0.03770619169076653,APP,1
SHEPARD_BMYB_TARGETS,SHEPARD_BMYB_TARGETS,1/11,76/21728,0.03781836344148337,0.0786834760794927,0.03770619169076653,ARID5B,1
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,1/11,77/21728,0.03830718655261123,0.0786834760794927,0.03770619169076653,CHL1,1
MAHAJAN_RESPONSE_TO_IL1A_UP,MAHAJAN_RESPONSE_TO_IL1A_UP,1/11,77/21728,0.03830718655261123,0.0786834760794927,0.03770619169076653,IL6ST,1
RODRIGUES_THYROID_CARCINOMA_DN,RODRIGUES_THYROID_CARCINOMA_DN,1/11,77/21728,0.03830718655261123,0.0786834760794927,0.03770619169076653,UGCG,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,1/11,77/21728,0.03830718655261123,0.0786834760794927,0.03770619169076653,APP,1
MORI_PRE_BI_LYMPHOCYTE_DN,MORI_PRE_BI_LYMPHOCYTE_DN,1/11,78/21728,0.03879578388982041,0.0786834760794927,0.03770619169076653,UBE2H,1
BASSO_HAIRY_CELL_LEUKEMIA_UP,BASSO_HAIRY_CELL_LEUKEMIA_UP,1/11,79/21728,0.039284155546966515,0.0786834760794927,0.03770619169076653,DLC1,1
REACTOME_PROTEIN_UBIQUITINATION,REACTOME_PROTEIN_UBIQUITINATION,1/11,79/21728,0.039284155546966515,0.0786834760794927,0.03770619169076653,UBE2H,1
RUAN_RESPONSE_TO_TNF_DN,RUAN_RESPONSE_TO_TNF_DN,1/11,79/21728,0.039284155546966515,0.0786834760794927,0.03770619169076653,ARL4A,1
WP_REGULATORY_CIRCUITS_OF_THE_STAT3_SIGNALING_PATHWAY,WP_REGULATORY_CIRCUITS_OF_THE_STAT3_SIGNALING_PATHWAY,1/11,79/21728,0.039284155546966515,0.0786834760794927,0.03770619169076653,IL6ST,1
BURTON_ADIPOGENESIS_8,BURTON_ADIPOGENESIS_8,1/11,80/21728,0.03977230161786993,0.0786834760794927,0.03770619169076653,APP,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,1/11,80/21728,0.03977230161786993,0.0786834760794927,0.03770619169076653,ARL4A,1
SCIBETTA_KDM5B_TARGETS_DN,SCIBETTA_KDM5B_TARGETS_DN,1/11,80/21728,0.03977230161786993,0.0786834760794927,0.03770619169076653,DPY19L1,1
TOOKER_GEMCITABINE_RESISTANCE_UP,TOOKER_GEMCITABINE_RESISTANCE_UP,1/11,80/21728,0.03977230161786993,0.0786834760794927,0.03770619169076653,ARID5B,1
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,1/11,80/21728,0.03977230161786993,0.0786834760794927,0.03770619169076653,ARL4A,1
BILANGES_SERUM_SENSITIVE_GENES,BILANGES_SERUM_SENSITIVE_GENES,1/11,81/21728,0.04026022219631631,0.0786834760794927,0.03770619169076653,ARID5B,1
FALVELLA_SMOKERS_WITH_LUNG_CANCER,FALVELLA_SMOKERS_WITH_LUNG_CANCER,1/11,81/21728,0.04026022219631631,0.0786834760794927,0.03770619169076653,IL6ST,1
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,1/11,81/21728,0.04026022219631631,0.0786834760794927,0.03770619169076653,IL6ST,1
ZAMORA_NOS2_TARGETS_DN,ZAMORA_NOS2_TARGETS_DN,1/11,81/21728,0.04026022219631631,0.0786834760794927,0.03770619169076653,APP,1
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,1/11,82/21728,0.04074791737605665,0.07903558313695516,0.03787492618072397,UBE2H,1
REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1/11,82/21728,0.04074791737605665,0.07903558313695516,0.03787492618072397,APP,1
LEE_AGING_CEREBELLUM_UP,LEE_AGING_CEREBELLUM_UP,1/11,84/21728,0.04172263191425163,0.08062192783430577,0.03863512413112339,UBE2H,1
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,1/11,88/21728,0.04366936032737945,0.08406760752162186,0.0402863406923193,DLC1,1
BOYLAN_MULTIPLE_MYELOMA_D_UP,BOYLAN_MULTIPLE_MYELOMA_D_UP,1/11,90/21728,0.04464137569928517,0.08529987773023262,0.04087686133293966,ARL4A,1
REACTOME_SPHINGOLIPID_METABOLISM,REACTOME_SPHINGOLIPID_METABOLISM,1/11,90/21728,0.04464137569928517,0.08529987773023262,0.04087686133293966,UGCG,1
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,1/11,91/21728,0.04512704650376387,0.08590852556642455,0.04116853365255651,ARID5B,1
GAVIN_FOXP3_TARGETS_CLUSTER_P7,GAVIN_FOXP3_TARGETS_CLUSTER_P7,1/11,92/21728,0.045612492845145014,0.08651225580223076,0.04145784939119803,APP,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,1/11,94/21728,0.0465827125120617,0.08738508843503545,0.04187612265778885,DLC1,1
KAYO_CALORIE_RESTRICTION_MUSCLE_UP,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,1/11,94/21728,0.0465827125120617,0.08738508843503545,0.04187612265778885,APP,1
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1/11,94/21728,0.0465827125120617,0.08738508843503545,0.04187612265778885,APP,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,1/11,96/21728,0.04755203544658704,0.0888790771619845,0.0425920623712971,CHL1,1
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,1/11,97/21728,0.04803636087234919,0.0894590198854619,0.042869978810563356,APP,1
TAKAO_RESPONSE_TO_UVB_RADIATION_DN,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,1/11,98/21728,0.048520462394720076,0.09003435982269357,0.043145689532071055,UGCG,1
REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,1/11,101/21728,0.04997142447294922,0.09173325778248535,0.043959824536353824,APP,1
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,1/11,101/21728,0.04997142447294922,0.09173325778248535,0.043959824536353824,UBE2H,1
WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,1/11,101/21728,0.04997142447294922,0.09173325778248535,0.043959824536353824,IL6ST,1
REACTOME_INTERLEUKIN_1_SIGNALING,REACTOME_INTERLEUKIN_1_SIGNALING,1/11,102/21728,0.05045463131304739,0.09229067791781623,0.04422694784511366,APP,1
BASSO_CD40_SIGNALING_UP,BASSO_CD40_SIGNALING_UP,1/11,103/21728,0.05093761471522806,0.09251566771599726,0.04433476601585779,ARID5B,1
REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1/11,103/21728,0.05093761471522806,0.09251566771599726,0.04433476601585779,APP,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,1/11,108/21728,0.05334918341086892,0.09621572025679517,0.04610788150745458,DLC1,1
REACTOME_AMYLOID_FIBER_FORMATION,REACTOME_AMYLOID_FIBER_FORMATION,1/11,108/21728,0.05334918341086892,0.09621572025679517,0.04610788150745458,APP,1
BRUECKNER_TARGETS_OF_MIRLET7A3_UP,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,1/11,110/21728,0.05431225007575835,0.09727002278376234,0.04661311761499158,B4GALT5,1
LE_EGR2_TARGETS_UP,LE_EGR2_TARGETS_UP,1/11,110/21728,0.05431225007575835,0.09727002278376234,0.04661311761499158,CHL1,1
DOANE_BREAST_CANCER_ESR1_UP,DOANE_BREAST_CANCER_ESR1_UP,1/11,111/21728,0.05479344931940544,0.09745270917015361,0.0467006634155559,UGCG,1
REACTOME_O_LINKED_GLYCOSYLATION,REACTOME_O_LINKED_GLYCOSYLATION,1/11,111/21728,0.05479344931940544,0.09745270917015361,0.0467006634155559,B4GALT5,1
BROWNE_HCMV_INFECTION_12HR_UP,BROWNE_HCMV_INFECTION_12HR_UP,1/11,113/21728,0.05575518009268787,0.09882125023324678,0.04735648690268226,B4GALT5,1
MATZUK_SPERMATOZOA,MATZUK_SPERMATOZOA,1/11,114/21728,0.05623571180765374,0.09932026924207102,0.047595623597470035,ARL4A,1
DAZARD_RESPONSE_TO_UV_SCC_DN,DAZARD_RESPONSE_TO_UV_SCC_DN,1/11,115/21728,0.05671602119833208,0.09932026924207102,0.047595623597470035,KBTBD2,1
LAIHO_COLORECTAL_CANCER_SERRATED_UP,LAIHO_COLORECTAL_CANCER_SERRATED_UP,1/11,115/21728,0.05671602119833208,0.09932026924207102,0.047595623597470035,IL6ST,1
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,1/11,116/21728,0.0571961083573016,0.09932026924207102,0.047595623597470035,ARL4A,1
IKEDA_MIR30_TARGETS_UP,IKEDA_MIR30_TARGETS_UP,1/11,116/21728,0.0571961083573016,0.09932026924207102,0.047595623597470035,B4GALT5,1
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,1/11,116/21728,0.0571961083573016,0.09932026924207102,0.047595623597470035,UGCG,1
FOROUTAN_INTEGRATED_TGFB_EMT_UP,FOROUTAN_INTEGRATED_TGFB_EMT_UP,1/11,118/21728,0.05815561635026345,0.09963995601345138,0.04774882184547946,DLC1,1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,1/11,118/21728,0.05815561635026345,0.09963995601345138,0.04774882184547946,IL6ST,1
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,1/11,118/21728,0.05815561635026345,0.09963995601345138,0.04774882184547946,IL6ST,1
WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,1/11,118/21728,0.05815561635026345,0.09963995601345138,0.04774882184547946,IL6ST,1
ZHU_CMV_ALL_DN,ZHU_CMV_ALL_DN,1/11,119/21728,0.05863503736924347,0.10012760534149882,0.04798251003463183,IL6ST,1
REACTOME_L1CAM_INTERACTIONS,REACTOME_L1CAM_INTERACTIONS,1/11,121/21728,0.05959321391441119,0.10142686076823627,0.04860513090265674,CHL1,1
WP_FRAGILE_X_SYNDROME,WP_FRAGILE_X_SYNDROME,1/11,122/21728,0.06007196962538164,0.10190426530510285,0.04883390964856454,APP,1
KARLSSON_TGFB1_TARGETS_UP,KARLSSON_TGFB1_TARGETS_UP,1/11,123/21728,0.06055050375174109,0.1020424882898194,0.048900147982424216,DPY19L1,1
TOOKER_GEMCITABINE_RESISTANCE_DN,TOOKER_GEMCITABINE_RESISTANCE_DN,1/11,123/21728,0.06055050375174109,0.1020424882898194,0.048900147982424216,UGCG,1
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,1/11,124/21728,0.061028816385794604,0.1021785394863141,0.04896534556583555,B4GALT5,1
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1/11,124/21728,0.061028816385794604,0.1021785394863141,0.04896534556583555,APP,1
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,1/11,125/21728,0.061506907619814366,0.10244429472238864,0.04909269908875474,UBE2H,1
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,1/11,126/21728,0.06198477754603671,0.10244429472238864,0.04909269908875474,APP,1
CHEBOTAEV_GR_TARGETS_DN,CHEBOTAEV_GR_TARGETS_DN,1/11,126/21728,0.06198477754603671,0.10244429472238864,0.04909269908875474,DPY19L1,1
WIERENGA_STAT5A_TARGETS_GROUP1,WIERENGA_STAT5A_TARGETS_GROUP1,1/11,126/21728,0.06198477754603671,0.10244429472238864,0.04909269908875474,ARL4A,1
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,1/11,130/21728,0.06389404601650395,0.10470442007613166,0.05017578189190009,IL6ST,1
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,1/11,131/21728,0.0643708107861043,0.10470442007613166,0.05017578189190009,IL6ST,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,1/11,131/21728,0.0643708107861043,0.10470442007613166,0.05017578189190009,ARID5B,1
WP_ADIPOGENESIS,WP_ADIPOGENESIS,1/11,131/21728,0.0643708107861043,0.10470442007613166,0.05017578189190009,IL6ST,1
XU_GH1_AUTOCRINE_TARGETS_DN,XU_GH1_AUTOCRINE_TARGETS_DN,1/11,131/21728,0.0643708107861043,0.10470442007613166,0.05017578189190009,ARID5B,1
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1/11,132/21728,0.06484735480061354,0.10514681503948063,0.05038778357411114,APP,1
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,1/11,133/21728,0.06532367815202966,0.10525508015718886,0.05043966569072741,APP,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,1/11,133/21728,0.06532367815202966,0.10525508015718886,0.05043966569072741,APP,1
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,1/11,135/21728,0.06627566323340872,0.10612364766969495,0.050855895053673196,UBE2H,1
TSENG_IRS1_TARGETS_DN,TSENG_IRS1_TARGETS_DN,1/11,135/21728,0.06627566323340872,0.10612364766969495,0.050855895053673196,IL6ST,1
ZHANG_BREAST_CANCER_PROGENITORS_DN,ZHANG_BREAST_CANCER_PROGENITORS_DN,1/11,137/21728,0.06722676676554573,0.10731229229034318,0.051425509719312534,UGCG,1
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,1/11,138/21728,0.06770198818028184,0.10740377137242241,0.05146934773939555,ARID5B,1
EPPERT_PROGENITOR,EPPERT_PROGENITOR,1/11,138/21728,0.06770198818028184,0.10740377137242241,0.05146934773939555,DLC1,1
REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,1/11,140/21728,0.06865177076606188,0.10857541591924864,0.05203081573848901,APP,1
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,1/11,141/21728,0.06912633212059072,0.10899059726988843,0.052229776287433735,UGCG,1
RUIZ_TNC_TARGETS_DN,RUIZ_TNC_TARGETS_DN,1/11,143/21728,0.07007479541138772,0.10976887435898165,0.052602737251693024,UGCG,1
PECE_MAMMARY_STEM_CELL_DN,PECE_MAMMARY_STEM_CELL_DN,1/11,144/21728,0.07054869753093662,0.10976887435898165,0.052602737251693024,APP,1
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,1/11,144/21728,0.07054869753093662,0.10976887435898165,0.052602737251693024,IL6ST,1
BROWNE_HCMV_INFECTION_30MIN_DN,BROWNE_HCMV_INFECTION_30MIN_DN,1/11,145/21728,0.07102238008871864,0.10976887435898165,0.052602737251693024,CHL1,1
KIM_ALL_DISORDERS_DURATION_CORR_DN,KIM_ALL_DISORDERS_DURATION_CORR_DN,1/11,145/21728,0.07102238008871864,0.10976887435898165,0.052602737251693024,ARL4A,1
WP_ENDODERM_DIFFERENTIATION,WP_ENDODERM_DIFFERENTIATION,1/11,145/21728,0.07102238008871864,0.10976887435898165,0.052602737251693024,APP,1
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,1/11,146/21728,0.0714958431762881,0.10976887435898165,0.052602737251693024,IL6ST,1
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,1/11,146/21728,0.0714958431762881,0.10976887435898165,0.052602737251693024,UGCG,1
KAAB_FAILED_HEART_ATRIUM_DN,KAAB_FAILED_HEART_ATRIUM_DN,1/11,147/21728,0.0719690868851689,0.10976887435898165,0.052602737251693024,APP,1
LEE_NEURAL_CREST_STEM_CELL_UP,LEE_NEURAL_CREST_STEM_CELL_UP,1/11,147/21728,0.0719690868851689,0.10976887435898165,0.052602737251693024,DLC1,1
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,1/11,147/21728,0.0719690868851689,0.10976887435898165,0.052602737251693024,UGCG,1
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,1/11,148/21728,0.07244211130684852,0.11016344737195308,0.05279182200499083,ARID5B,1
REACTOME_RHOA_GTPASE_CYCLE,REACTOME_RHOA_GTPASE_CYCLE,1/11,149/21728,0.07291491653278126,0.1105553601706477,0.052979631947433055,DLC1,1
GOLDRATH_HOMEOSTATIC_PROLIFERATION,GOLDRATH_HOMEOSTATIC_PROLIFERATION,1/11,150/21728,0.0733875026543872,0.11061928552596781,0.053010265846972084,APP,1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,1/11,150/21728,0.0733875026543872,0.11061928552596781,0.053010265846972084,DLC1,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,1/11,154/21728,0.07527565792477053,0.11285227549553861,0.05408034500502978,UGCG,1
KEGG_JAK_STAT_SIGNALING_PATHWAY,KEGG_JAK_STAT_SIGNALING_PATHWAY,1/11,155/21728,0.07574714989486542,0.11285227549553861,0.05408034500502978,IL6ST,1
REACTOME_CDC42_GTPASE_CYCLE,REACTOME_CDC42_GTPASE_CYCLE,1/11,155/21728,0.07574714989486542,0.11285227549553861,0.05408034500502978,DLC1,1
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,1/11,155/21728,0.07574714989486542,0.11285227549553861,0.05408034500502978,APP,1
RUIZ_TNC_TARGETS_UP,RUIZ_TNC_TARGETS_UP,1/11,156/21728,0.0762184233084453,0.1128999123358527,0.05410317322668346,ARID5B,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,1/11,156/21728,0.0762184233084453,0.1128999123358527,0.05410317322668346,DLC1,1
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,1/11,159/21728,0.07763093312175862,0.11466178053041359,0.0549474844237493,B4GALT5,1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,1/11,160/21728,0.07810133322077395,0.11469738650136518,0.054964547289206335,B4GALT5,1
RODRIGUES_NTN1_TARGETS_DN,RODRIGUES_NTN1_TARGETS_DN,1/11,160/21728,0.07810133322077395,0.11469738650136518,0.054964547289206335,ARID5B,1
VERHAAK_GLIOBLASTOMA_CLASSICAL,VERHAAK_GLIOBLASTOMA_CLASSICAL,1/11,161/21728,0.07857151521885364,0.11505914194441814,0.0551379054167394,DLC1,1
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,1/11,162/21728,0.07904147920701077,0.1151543622071965,0.055183536261486754,APP,1
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,1/11,164/21728,0.07998075351744971,0.1151543622071965,0.055183536261486754,ARID5B,1
DARWICHE_PAPILLOMA_RISK_LOW_UP,DARWICHE_PAPILLOMA_RISK_LOW_UP,1/11,164/21728,0.07998075351744971,0.1151543622071965,0.055183536261486754,APP,1
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,1/11,164/21728,0.07998075351744971,0.1151543622071965,0.055183536261486754,IL6ST,1
REACTOME_PROTEIN_LOCALIZATION,REACTOME_PROTEIN_LOCALIZATION,1/11,164/21728,0.07998075351744971,0.1151543622071965,0.055183536261486754,APP,1
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,1/11,164/21728,0.07998075351744971,0.1151543622071965,0.055183536261486754,IL6ST,1
IBRAHIM_NRF1_DOWN,IBRAHIM_NRF1_DOWN,1/11,166/21728,0.08091915687953155,0.11558884250099007,0.055391745126421615,DLC1,1
KEGG_ALZHEIMERS_DISEASE,KEGG_ALZHEIMERS_DISEASE,1/11,166/21728,0.08091915687953155,0.11558884250099007,0.055391745126421615,APP,1
KIM_WT1_TARGETS_8HR_UP,KIM_WT1_TARGETS_8HR_UP,1/11,167/21728,0.08138803218211565,0.11558884250099007,0.055391745126421615,IL6ST,1
YAMAZAKI_TCEB3_TARGETS_UP,YAMAZAKI_TCEB3_TARGETS_UP,1/11,167/21728,0.08138803218211565,0.11558884250099007,0.055391745126421615,APP,1
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,1/11,168/21728,0.08185669002015639,0.11558884250099007,0.055391745126421615,ARL4A,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,1/11,168/21728,0.08185669002015639,0.11558884250099007,0.055391745126421615,APP,1
WHITFIELD_CELL_CYCLE_G2,WHITFIELD_CELL_CYCLE_G2,1/11,168/21728,0.08185669002015639,0.11558884250099007,0.055391745126421615,KBTBD2,1
SERVITJA_ISLET_HNF1A_TARGETS_UP,SERVITJA_ISLET_HNF1A_TARGETS_UP,1/11,169/21728,0.08232513048443202,0.11593182758629604,0.055556108243279285,CHL1,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,1/11,170/21728,0.08279335366568663,0.11627263329006264,0.05571942697086762,UGCG,1
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,1/11,173/21728,0.0841967204182682,0.11760085406247243,0.056355928426415215,ARL4A,1
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,1/11,173/21728,0.0841967204182682,0.11760085406247243,0.056355928426415215,KBTBD2,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,1/11,176/21728,0.08559813488723989,0.11923425835241545,0.057138677973510577,DPY19L1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,1/11,178/21728,0.08653132780523065,0.12020838511321232,0.05760549276365284,IL6ST,1
FERNANDEZ_BOUND_BY_MYC,FERNANDEZ_BOUND_BY_MYC,1/11,181/21728,0.08792949389940741,0.12113494529940914,0.05804951300442708,APP,1
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,1/11,182/21728,0.08839511675025047,0.12113494529940914,0.05804951300442708,DLC1,1
DARWICHE_PAPILLOMA_RISK_HIGH_DN,DARWICHE_PAPILLOMA_RISK_HIGH_DN,1/11,182/21728,0.08839511675025047,0.12113494529940914,0.05804951300442708,APP,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,1/11,182/21728,0.08839511675025047,0.12113494529940914,0.05804951300442708,APP,1
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,1/11,182/21728,0.08839511675025047,0.12113494529940914,0.05804951300442708,UGCG,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,1/11,183/21728,0.08886052349469253,0.12113494529940914,0.05804951300442708,UGCG,1
REACTOME_RAC1_GTPASE_CYCLE,REACTOME_RAC1_GTPASE_CYCLE,1/11,184/21728,0.08932571422300783,0.12113494529940914,0.05804951300442708,DLC1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,1/11,184/21728,0.08932571422300783,0.12113494529940914,0.05804951300442708,ARID5B,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,1/11,184/21728,0.08932571422300783,0.12113494529940914,0.05804951300442708,ARID5B,1
FOROUTAN_PRODRANK_TGFB_EMT_UP,FOROUTAN_PRODRANK_TGFB_EMT_UP,1/11,185/21728,0.08979068902543752,0.12113494529940914,0.05804951300442708,DLC1,1
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,1/11,185/21728,0.08979068902543752,0.12113494529940914,0.05804951300442708,DLC1,1
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1/11,186/21728,0.09025544799218865,0.12144319441880883,0.0581972301740759,B4GALT5,1
DARWICHE_SKIN_TUMOR_PROMOTER_DN,DARWICHE_SKIN_TUMOR_PROMOTER_DN,1/11,189/21728,0.0916484307799399,0.12299554417986712,0.058941137288734194,APP,1
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,1/11,190/21728,0.09211232730537822,0.123253324189394,0.05906466897464304,UGCG,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,1/11,191/21728,0.09257600844567171,0.123253324189394,0.05906466897464304,CHL1,1
SHEPARD_CRASH_AND_BURN_MUTANT_DN,SHEPARD_CRASH_AND_BURN_MUTANT_DN,1/11,191/21728,0.09257600844567171,0.123253324189394,0.05906466897464304,ARID5B,1
FOROUTAN_TGFB_EMT_UP,FOROUTAN_TGFB_EMT_UP,1/11,192/21728,0.0930394742908266,0.123253324189394,0.05906466897464304,DLC1,1
KASLER_HDAC7_TARGETS_1_UP,KASLER_HDAC7_TARGETS_1_UP,1/11,192/21728,0.0930394742908266,0.123253324189394,0.05906466897464304,UGCG,1
BURTON_ADIPOGENESIS_6,BURTON_ADIPOGENESIS_6,1/11,193/21728,0.09350272493081535,0.12354858769778686,0.0592061632629165,ARL4A,1
ALONSO_METASTASIS_UP,ALONSO_METASTASIS_UP,1/11,194/21728,0.09396576045557792,0.12384205352350526,0.05934679607720711,ARID5B,1
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,1/11,195/21728,0.09442858095502038,0.12413373557769943,0.059486574083927234,IL6ST,1
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,1/11,198/21728,0.0958157531999847,0.125565866326858,0.06017287061332126,APP,1
YAMAZAKI_TCEB3_TARGETS_DN,YAMAZAKI_TCEB3_TARGETS_DN,1/11,199/21728,0.09627771449653821,0.125565866326858,0.06017287061332126,ARL4A,1
FISCHER_G1_S_CELL_CYCLE,FISCHER_G1_S_CELL_CYCLE,1/11,200/21728,0.0967394612168011,0.125565866326858,0.06017287061332126,ARID5B,1
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,1/11,200/21728,0.0967394612168011,0.125565866326858,0.06017287061332126,IL6ST,1
JIANG_HYPOXIA_NORMAL,JIANG_HYPOXIA_NORMAL,1/11,200/21728,0.0967394612168011,0.125565866326858,0.06017287061332126,UGCG,1
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,1/11,201/21728,0.09720099345047883,0.12584713005931011,0.06030765601859219,ARL4A,1
SHEPARD_BMYB_MORPHOLINO_DN,SHEPARD_BMYB_MORPHOLINO_DN,1/11,202/21728,0.09766231128724412,0.12612670352171726,0.06044163142347296,ARID5B,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,1/11,203/21728,0.09812341481673581,0.1264045995383514,0.06057480297352903,ARL4A,1
KYNG_DNA_DAMAGE_UP,KYNG_DNA_DAMAGE_UP,1/11,205/21728,0.09904497931228917,0.12727279841629158,0.06099085568177807,CHL1,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,1/11,206/21728,0.09950544045746257,0.12754562692053806,0.061121598810988956,CHL1,1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1/11,207/21728,0.09996568765358593,0.12781682451229645,0.06125156038475808,UBE2H,1
CAIRO_HEPATOBLASTOMA_UP,CAIRO_HEPATOBLASTOMA_UP,1/11,213/21728,0.10272268290842079,0.13101602733232826,0.06278466187951016,ARL4A,1
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,1/11,214/21728,0.10318143496456811,0.13127539002917823,0.06290895201070594,IL6ST,1
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,1/11,215/21728,0.1036399737865159,0.13153320129943005,0.06303249867717928,UBE2H,1
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,1/11,216/21728,0.1040982994634716,0.13178947271976452,0.06315530742663301,APP,1
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,1/11,217/21728,0.10455641208460886,0.13204421575304412,0.06327738375222676,DLC1,1
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,1/11,219/21728,0.10547199851595623,0.13254916194914793,0.06351936083575797,DLC1,1
WP_CILIARY_LANDSCAPE,WP_CILIARY_LANDSCAPE,1/11,219/21728,0.10547199851595623,0.13254916194914793,0.06351936083575797,UBE2H,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,1/11,222/21728,0.10684378247177462,0.13394561997681012,0.06418856251192621,ARL4A,1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,1/11,223/21728,0.10730061862879181,0.1341094977471792,0.06426709496792941,B4GALT5,1
BROWNE_HCMV_INFECTION_16HR_UP,BROWNE_HCMV_INFECTION_16HR_UP,1/11,224/21728,0.10775724235327822,0.1341094977471792,0.06426709496792941,ARL4A,1
THUM_SYSTOLIC_HEART_FAILURE_DN,THUM_SYSTOLIC_HEART_FAILURE_DN,1/11,224/21728,0.10775724235327822,0.1341094977471792,0.06426709496792941,DLC1,1
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,1/11,228/21728,0.10958161470359673,0.13586880310316898,0.06511017801790198,UGCG,1
KONDO_EZH2_TARGETS,KONDO_EZH2_TARGETS,1/11,229/21728,0.11003717759839926,0.13586880310316898,0.06511017801790198,APP,1
RAO_BOUND_BY_SALL4,RAO_BOUND_BY_SALL4,1/11,229/21728,0.11003717759839926,0.13586880310316898,0.06511017801790198,IL6ST,1
BENPORATH_MYC_TARGETS_WITH_EBOX,BENPORATH_MYC_TARGETS_WITH_EBOX,1/11,230/21728,0.11049252859362768,0.13586880310316898,0.06511017801790198,APP,1
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,1/11,230/21728,0.11049252859362768,0.13586880310316898,0.06511017801790198,APP,1
DELYS_THYROID_CANCER_DN,DELYS_THYROID_CANCER_DN,1/11,233/21728,0.11185731106880659,0.1372187539125694,0.06575709280266484,ARL4A,1
FISCHER_G2_M_CELL_CYCLE,FISCHER_G2_M_CELL_CYCLE,1/11,236/21728,0.11322018963941072,0.1385599463682312,0.06639981046521831,ARL4A,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,1/11,238/21728,0.11412771880909878,0.13900864328880752,0.06661483213102798,UBE2H,1
SENESE_HDAC1_AND_HDAC2_TARGETS_DN,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,1/11,238/21728,0.11412771880909878,0.13900864328880752,0.06661483213102798,ARID5B,1
DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/11,242/21728,0.11594024462713504,0.1405502022130835,0.06735356812996425,UGCG,1
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,1/11,242/21728,0.11594024462713504,0.1405502022130835,0.06735356812996425,UGCG,1
CHICAS_RB1_TARGETS_GROWING,CHICAS_RB1_TARGETS_GROWING,1/11,243/21728,0.11639284898853763,0.1407668808943726,0.06745740350047755,ARL4A,1
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,1/11,245/21728,0.11729742581770553,0.14152787997723157,0.06782208460919965,UBE2H,1
BILD_E2F3_ONCOGENIC_SIGNATURE,BILD_E2F3_ONCOGENIC_SIGNATURE,1/11,248/21728,0.11865271265060806,0.14249414556638446,0.06828513221899235,DPY19L1,1
ZHENG_GLIOBLASTOMA_PLASTICITY_UP,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,1/11,248/21728,0.11865271265060806,0.14249414556638446,0.06828513221899235,CHL1,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,1/11,250/21728,0.11955518596040093,0.14324327641875545,0.06864412591027805,IL6ST,1
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,1/11,251/21728,0.12000610750590956,0.14344916106520353,0.06874278863251614,APP,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,1/11,256/21728,0.12225756765936802,0.14580136839191454,0.0698699983692566,CHL1,1
MASSARWEH_TAMOXIFEN_RESISTANCE_DN,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,1/11,257/21728,0.12270723079069001,0.14599888107966358,0.06996464913504255,DLC1,1
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1/11,261/21728,0.12450378991244637,0.14672707119526449,0.07031360774051175,APP,1
BOQUEST_STEM_CELL_UP,BOQUEST_STEM_CELL_UP,1/11,262/21728,0.12495240678070707,0.14672707119526449,0.07031360774051175,CHL1,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,1/11,262/21728,0.12495240678070707,0.14672707119526449,0.07031360774051175,UBE2H,1
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,1/11,262/21728,0.12495240678070707,0.14672707119526449,0.07031360774051175,B4GALT5,1
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,1/11,265/21728,0.1262970037989436,0.14672707119526449,0.07031360774051175,UGCG,1
FOSTER_KDM1A_TARGETS_UP,FOSTER_KDM1A_TARGETS_UP,1/11,265/21728,0.1262970037989436,0.14672707119526449,0.07031360774051175,APP,1
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,1/11,265/21728,0.1262970037989436,0.14672707119526449,0.07031360774051175,IL6ST,1
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,1/11,265/21728,0.1262970037989436,0.14672707119526449,0.07031360774051175,CHL1,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,1/11,265/21728,0.1262970037989436,0.14672707119526449,0.07031360774051175,DLC1,1
KOYAMA_SEMA3B_TARGETS_UP,KOYAMA_SEMA3B_TARGETS_UP,1/11,266/21728,0.1267447852348199,0.14672707119526449,0.07031360774051175,DLC1,1
SENESE_HDAC1_TARGETS_DN,SENESE_HDAC1_TARGETS_DN,1/11,266/21728,0.1267447852348199,0.14672707119526449,0.07031360774051175,ARID5B,1
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,1/11,266/21728,0.1267447852348199,0.14672707119526449,0.07031360774051175,APP,1
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1/11,268/21728,0.12763972227648956,0.14743105000025986,0.0706509639567086,DPY19L1,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,1/11,272/21728,0.12942709548824605,0.14882668250773706,0.0713197700323786,B4GALT5,1
REACTOME_CHROMATIN_MODIFYING_ENZYMES,REACTOME_CHROMATIN_MODIFYING_ENZYMES,1/11,272/21728,0.12942709548824605,0.14882668250773706,0.0713197700323786,ARID5B,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,1/11,274/21728,0.13031953305644361,0.1495183928370804,0.07165124702821384,ARL4A,1
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,1/11,280/21728,0.13299185798804103,0.15190625556856244,0.07279554331976983,APP,1
MULLIGHAN_MLL_SIGNATURE_2_DN,MULLIGHAN_MLL_SIGNATURE_2_DN,1/11,280/21728,0.13299185798804103,0.15190625556856244,0.07279554331976983,APP,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,1/11,285/21728,0.1352130906574417,0.1541009503279934,0.07384727089238267,IL6ST,1
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,1/11,290/21728,0.1374291487668402,0.15628004970388468,0.07489152494513415,DLC1,1
BASAKI_YBX1_TARGETS_UP,BASAKI_YBX1_TARGETS_UP,1/11,293/21728,0.13875630435881425,0.1567488800888583,0.07511619484086185,DLC1,1
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,1/11,293/21728,0.13875630435881425,0.1567488800888583,0.07511619484086185,B4GALT5,1
WANG_MLL_TARGETS,WANG_MLL_TARGETS,1/11,293/21728,0.13875630435881425,0.1567488800888583,0.07511619484086185,ARID5B,1
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,1/11,296/21728,0.14008160335663933,0.15789900027480838,0.07566734807353095,IL6ST,1
MUELLER_PLURINET,MUELLER_PLURINET,1/11,299/21728,0.1414050480981589,0.15904200158086143,0.07621508984214945,ARL4A,1
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,1/11,301/21728,0.14228631560341887,0.15968376903964476,0.07652263353527929,APP,1
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,1/11,303/21728,0.1431667607239706,0.16032181919852045,0.07682839584774481,DLC1,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,1/11,304/21728,0.14360667510586267,0.16046485000959437,0.0768969381573727,DPY19L1,1
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,1/11,305/21728,0.14404638415057125,0.1606070313522638,0.07696507339018992,B4GALT5,1
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1/11,308/21728,0.1453642801240752,0.16116737355427405,0.07723359699303733,UBE2H,1
REACTOME_LEISHMANIA_INFECTION,REACTOME_LEISHMANIA_INFECTION,1/11,308/21728,0.1453642801240752,0.16116737355427405,0.07723359699303733,APP,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,1/11,309/21728,0.14580316868236853,0.16116737355427405,0.07723359699303733,DLC1,1
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,1/11,309/21728,0.14580316868236853,0.16116737355427405,0.07723359699303733,ARID5B,1
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,1/11,314/21728,0.14799453960263287,0.16323861235140194,0.07822616278973593,APP,1
PASINI_SUZ12_TARGETS_DN,PASINI_SUZ12_TARGETS_DN,1/11,316/21728,0.14886965603675184,0.16385225525244207,0.07852022881235192,APP,1
ZWANG_DOWN_BY_2ND_EGF_PULSE,ZWANG_DOWN_BY_2ND_EGF_PULSE,1/11,317/21728,0.1493069077546484,0.16398237304677196,0.07858258302876232,ARL4A,1
HORIUCHI_WTAP_TARGETS_DN,HORIUCHI_WTAP_TARGETS_DN,1/11,318/21728,0.14974395525428386,0.16411171215501472,0.07864456408821104,DPY19L1,1
LEI_MYB_TARGETS,LEI_MYB_TARGETS,1/11,323/21728,0.151926132482042,0.16614900445908423,0.07962086226382492,ARID5B,1
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,1/11,327/21728,0.15366820708329532,0.16734207296782583,0.0801925969167955,IL6ST,1
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,1/11,327/21728,0.15366820708329532,0.16734207296782583,0.0801925969167955,IL6ST,1
REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1/11,331/21728,0.15540702790403327,0.16887782736294527,0.08092855130642881,APP,1
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,1/11,336/21728,0.1575759866344142,0.1708735382491327,0.08188492310116127,APP,1
BLUM_RESPONSE_TO_SALIRASIB_DN,BLUM_RESPONSE_TO_SALIRASIB_DN,1/11,341/21728,0.15973988054668564,0.17285536547578192,0.08283464165745029,B4GALT5,1
YAGI_AML_WITH_11Q23_REARRANGED,YAGI_AML_WITH_11Q23_REARRANGED,1/11,345/21728,0.16146735616280294,0.17435760728504351,0.08355453636022975,DPY19L1,1
RICKMAN_METASTASIS_UP,RICKMAN_METASTASIS_UP,1/11,351/21728,0.16405251648432517,0.1767777640942204,0.08471430841295838,B4GALT5,1
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,1/11,353/21728,0.16491262514721705,0.17733282285704932,0.08498030011990484,DPY19L1,1
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,1/11,359/21728,0.16748812629453236,0.17972629836198253,0.08612728612882226,DLC1,1
KOYAMA_SEMA3B_TARGETS_DN,KOYAMA_SEMA3B_TARGETS_DN,1/11,364/21728,0.1696288588674585,0.18164423637057012,0.08704638810303791,ARID5B,1
WANG_LMO4_TARGETS_UP,WANG_LMO4_TARGETS_UP,1/11,369/21728,0.17176458598873734,0.18354885072393137,0.0879591052004914,DPY19L1,1
HATADA_METHYLATED_IN_LUNG_CANCER_UP,HATADA_METHYLATED_IN_LUNG_CANCER_UP,1/11,377/21728,0.17517136433337244,0.18641424693033837,0.08933224202682609,DLC1,1
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1/11,377/21728,0.17517136433337244,0.18641424693033837,0.08933224202682609,UBE2H,1
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,1/11,378/21728,0.1755963146866273,0.1864803837787736,0.0893639357039382,IL6ST,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,1/11,382/21728,0.17729412653878962,0.187895218641109,0.09004194380917369,ARID5B,1
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,1/11,384/21728,0.17814183990230537,0.18840515578145053,0.09028631262105144,B4GALT5,1
STEIN_ESRRA_TARGETS_UP,STEIN_ESRRA_TARGETS_UP,1/11,385/21728,0.1785653987366882,0.18846532844077563,0.09031514817763976,B4GALT5,1
CHYLA_CBFA2T3_TARGETS_UP,CHYLA_CBFA2T3_TARGETS_UP,1/11,387/21728,0.17941192112930493,0.1889707529927515,0.09055735449580965,APP,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,1/11,390/21728,0.18068021778271115,0.18991744773070252,0.09101102348757811,APP,1
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,1/11,395/21728,0.1827900859484004,0.19135255433294868,0.09169874608623794,IL6ST,1
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,1/11,395/21728,0.1827900859484004,0.19135255433294868,0.09169874608623794,DLC1,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,1/11,399/21728,0.18447442285917437,0.19272327916588541,0.09235561606556868,ARL4A,1
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,1/11,401/21728,0.1853154072743749,0.19320916701628538,0.09258846013067946,UGCG,1
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,1/11,408/21728,0.1882526478749268,0.19587421256621937,0.09386558619802444,CHL1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,1/11,409/21728,0.18867146686523528,0.1959134019570322,0.09388436628700703,ARID5B,1
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,1/11,411/21728,0.18950851556860948,0.19602880955828367,0.09393967117886214,DPY19L1,1
PEDRIOLI_MIR31_TARGETS_DN,PEDRIOLI_MIR31_TARGETS_DN,1/11,412/21728,0.18992674544751997,0.19602880955828367,0.09393967117886214,UGCG,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,1/11,412/21728,0.18992674544751997,0.19602880955828367,0.09393967117886214,B4GALT5,1
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,1/11,419/21728,0.19284886550622615,0.19864592559158364,0.09519382877008106,B4GALT5,1
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,1/11,423/21728,0.19451434281771152,0.19996074441660744,0.09582390783019894,IL6ST,1
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,1/11,430/21728,0.19742141242543854,0.20254412372589903,0.09706189832451438,KBTBD2,1
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,1/11,434/21728,0.19907830944510085,0.20383715349558135,0.09768153577302076,UBE2H,1
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,1/11,441/21728,0.20197039840376274,0.20638724608257264,0.09890357481737048,APP,1
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,1/11,450/21728,0.20567484775325862,0.20934034008945532,0.10031873762222515,APP,1
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,1/11,450/21728,0.20567484775325862,0.20934034008945532,0.10031873762222515,DLC1,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,1/11,454/21728,0.20731624610595456,0.21059397331711588,0.10091949571207275,B4GALT5,1
REACTOME_GPCR_LIGAND_BINDING,REACTOME_GPCR_LIGAND_BINDING,1/11,463/21728,0.21099812436053744,0.2139113134542727,0.10250921021564573,APP,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,1/11,466/21728,0.2122219578407054,0.2147285163978791,0.10290082497870921,DPY19L1,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,1/11,476/21728,0.2162889496828917,0.21841359555403997,0.10466676502077688,ARL4A,1
LIM_MAMMARY_STEM_CELL_UP,LIM_MAMMARY_STEM_CELL_UP,1/11,480/21728,0.21791039486866115,0.21961949600488595,0.10524464891489517,IL6ST,1
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,1/11,482/21728,0.21871997328909698,0.22000404358237935,0.10542892934318404,CHL1,1
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,1/11,484/21728,0.21952878978927326,0.2203863241243876,0.10561212337724084,CHL1,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,1/11,493/21728,0.2231590525708198,0.223594060470568,0.1071493142537639,ARID5B,1
PILON_KLF1_TARGETS_UP,PILON_KLF1_TARGETS_UP,1/11,497/21728,0.22476756976239054,0.22476756976239054,0.10771167586401677,DLC1,1
